Plain-English translation of NCT04867954 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial tested an advanced type of MRI scan called 4D flow MRI to see if it could safely and accurately predict which patients with cirrhosis (severe liver scarring) were at risk for dangerous bleeding from enlarged veins in the food pipe. Researchers worked with healthy volunteers and patients with different stages of liver disease to see if the imaging could spot warning signs before bleeding happens.
Patients with advanced liver disease often develop enlarged, fragile blood vessels in the esophagus that can rupture and cause life-threatening bleeding. Currently, doctors use an uncomfortable procedure called endoscopy to check for these vessels. This trial was designed to see if a non-invasive MRI scan could predict which patients actually need that procedure, avoiding unnecessary tests while catching high-risk patients.
Participants came for a single research visit lasting about 1.5 to 2 hours. They fasted beforehand, had an IV placed for a small blood draw and contrast injection, and then underwent an advanced MRI scan. Some participants were also studied after eating a meal to see how blood flow patterns changed. The entire process was non-invasive and designed to be safe.
AI-generated summary from trial data · Jul 11, 2026 · Not medical advice
United States